Differential [qlco]
effects [qlco]
Inhibition [menp]
Angiotensin 2 [aapp, bacs, phsu]
antagonism [socb]
Fibrinolysis [phsf]
Insulin Sensitivity [patf]
hypertensive [fndg]
postmenopausal [tmco]
Women [popg]
Study [mnob]
effects [qlco]
trandolapril [orch, phsu]
Losartan [orch, phsu]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Levels [qlco]
Insulin Sensitivity [patf]
hypertensive [fndg]
postmenopausal [tmco]
Women [popg]
Study [mnob]
hypertensive [fndg]
Diastolic blood pressure [clna]
>90 [qnco]
mmHg [qnco]
postmenopausal [tmco]
Women [popg]
Aged [orga]
Take [hlca]
Hormone replacement therapy [topp]
diabetic [fndg]
Obese [dsyn]
Smoking [inbe]
Patients [podg]
Excluded [idcn]
placebo [topp]
randomized [resa]
Receive [qlco]
mg% [qnco]
Oral [spco]
trandolapril [orch, phsu]
N NOS [aapp, imft]
mg% [qnco]
Oral [spco]
Losartan [orch, phsu]
N NOS [aapp, imft]
weeks [tmco]
DOUBLE BLIND [resa]
Parallel [qlco]
Group [idcn]
Design [acty]
End [spco]
placebo [topp]
Active Treatment [topp]
Blood Pressure [orgf]
Measured [qlco]
Plasma sample [bdsu]
Draw [inpr]
Evaluate [ftcn]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
antigen levels [lbpr]
Insulin Sensitivity [patf]
Assessed [acty]
trandolapril [orch, phsu]
Losartan [orch, phsu]
Reduced [qlco]
Systolic blood pressure [clna]
mmHg [qnco]
mmHg [qnco]
P NOS [aapp, imft]
placebo [topp]
Diastolic blood pressure [clna]
mmHg [qnco]
mmHg [qnco]
P NOS [aapp, imft]
placebo [topp]
Treatments [topp]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
antigen levels [lbpr]
Decreased [qnco]
trandolapril [orch, phsu]
ng/dL [qnco]
ng/dL [qnco]
P NOS [aapp, imft]
Losartan [orch, phsu]
ng/dL [qnco]
ng/dL [qnco]
P NOS [aapp, imft]
Not significant [fndg]
Glucose [bacs, carb, phsu]
Infusion Rate [tmco]
Increased [qnco]
trandolapril [orch, phsu]
mg kg [qnco]
9-MG [nnon]
KG [geoa]
P NOS [aapp, imft]
Modified [ftcn]
Losartan [orch, phsu]
mg kg [qnco]
6 9 [fndg]
mg kg [qnco]
P NOS [aapp, imft]
Not significant [fndg]
trandolapril [orch, phsu]
Group [idcn]
Pai [idcn]
Decrease [qlco]
Correlated [qlco]
Glucose [bacs, carb, phsu]
Infusion Rate [tmco]
R- [spco]
P NOS [aapp, imft]
effects [qlco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
antagonists [chvf]
Fibrinolysis [phsf]
Suggest [idcn]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Decrease [qlco]
Induced [ftcn]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Action [ftcn]
Insulin Sensitivity [patf]
Dependent [qlco]
Angiotensin 2 [aapp, bacs, phsu]
antagonism [socb]
Mechanisms [ftcn]
Seen [qlco]
findings [ftcn]
Apply [hlca]
postmenopausal [tmco]
Women [popg]
American [popg]
Journal [inpr, mnob]
Hypertension [dsyn]
LTD [ortf]
